GlassScriptPhysician profile
Petra Grinnell
NPI 1386959120
$5,031.61
in general payments reported to CMS, 2019-2025
35 companies · $3,029 in 2025
The $3,029 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.46 · 2023: $533 · 2024: $1,434 · 2025: $3,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,995.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $834.86 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $526.93 | 2023-2025 | Tepezza, Evenity, Prolia |
| Corcept Therapeutics | $337.40 | 2024-2025 | Korlym |
| Novo Nordisk INC | $296.32 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.57 | 2023-2025 | Jardiance, Synjardy |
| Radius Health, INC. | $235.11 | 2022-2025 | Tymlos |
| Cequr Corporation | $202.73 | 2024-2025 | Cequr Simplicity |
| Dexcom, INC. | $195.21 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $173.94 | 2024-2025 | |
| Abbvie INC. | $155.19 | 2024-2025 | |
| Mannkind Corporation | $134.08 | 2023-2025 | Afrezza |
| Kyowa Kirin, INC. | $130.79 | 2024-2025 | Crysvita |
| Ascendis Pharma Endocrinology INC | $115.22 | 2025 | Yorvipath |
| Sanofi-Aventis U.S. LLC | $114.91 | 2024-2025 | |
| Insulet Corporation | $110.46 | 2025 | Omnipod |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $106.59 | 2023-2025 | Minimed 780g |
| Beta Bionics, INC. | $105.14 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Tandem Diabetes Care, INC. | $102.22 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Recordati_rare_diseases_inc. | $100.12 | 2025 | Isturisa, Signifor Lar |
| Xeris Pharmaceuticals, INC. | $97.89 | 2024-2025 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $75.94 | 2024-2025 | |
| Acella Pharmaceuticals, LLC | $71.90 | 2024-2025 | NP Thyroid 60 |
| Abbott Laboratories | $70.05 | 2025 | Freestyle Libre 3 |
| Neurocrine Biosciences, INC. | $58.67 | 2025 | |
| Ascensia Diabetes Care US INC. | $58.39 | 2024 | |
| Soleno Therapeutics, INC. | $58.18 | 2025 | Vykat Xr |
| Alexion Pharmaceuticals, INC. | $49.88 | 2024-2025 | Strensiq |
| Chiesi USA, INC. | $48.81 | 2024-2025 | Mycapssa |
| Madrigal Pharmaceuticals | $33.55 | 2025 | Rezdiffra |
| Tolmar, INC. | $33.23 | 2023-2024 | |
| Amneal Pharmaceuticals LLC | $30.03 | 2025 | Unithroid |
| Sequel Med Tech, LLC | $25.60 | 2025 | Twiist |
| Antares Pharma, INC. | $20.28 | 2024 | Xyosted |
| Amphastar Pharmaceuticals, INC. | $18.40 | 2024 | |
| Ibsa Pharma INC. | $16.02 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Petra Grinnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.